You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Kazakhstan

Apr 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health records double-digit growth

Consumer health in Kazakhstan recorded a double-digit current value growth rate in 2011, which was also stronger compared to the review period as a whole. Growth returned in line with increasing purchasing power and a rebound in confident consumer spending after the global economic crisis. Growth was also boosted by a strong self-medication trend. However, the growth rate in 2011 was also exaggerated by the inflation rate and currency fluctuations which increased the price of imported products towards the end of the review period.

Unit price increase stimulates value growth in 2011

Consumer health in 2011 encountered a unit price increase, largely due to the inflationary pressure and a dependence mostly on imports by international companies. However, despite this, manufacturers and retailers intended to keep price increases to a minimum. They were cautious of losing volume growth due to the strong influence of under-the-counter and prescription sales to non-prescription medicines and existence of traditional remedies across the country.

Competitive landscape in hands of multinationals

In 2011, the top-performing companies in Kazakhstan consumer health were international companies led by Bayer AG and Novartis AG. Advertising and promotional campaigns remained the main tools for multinationals. They largely benefit from their brands’ recognition as more qualitative and effective, in most cases with no side effects. Local companies are also active in a number of categories, manufacturing eye, nasal and ear care medicines, iodine and “brilliant green” brands, such as those offered by LeKos TOO.

Chemists/pharmacies continues to dominate consumer health distribution

Chemists/pharmacies continued to be the dominant distribution channel for consumer health at the end of the review period. Pharmaceuticals is heavily regulated and a large number of small independent chemists/pharmacies dominate retail sales. In addition, consumers still appreciate expert pharmaceutical advice and believe that the products sold through chemists/pharmacies are more controlled. These are major factors influencing purchasing decisions within consumer healthcare.

Good growth opportunities in constant value terms

In constant value terms, consumer health in Kazakhstan is predicted to record a higher growth rate compared to that achieved during the review period. Healthcare in the country has more scope for value as opposed to volume growth due to rising unit prices and high dependence on imports. The ongoing health and wellness trend in the country and self-medication tendency are both expected to have a positive impact on consumer health in the long-term. On the other hand, prescription sales of consumer health remain strong. As the economy improves and disposable income levels rise, many are expected to trade up to prescription pharmaceuticals, believing these to offer a stronger or more rapid effect.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Kazakhstan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Kazakhstan, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Kazakhstan for free:

The Consumer Health in Kazakhstan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Kazakhstan?
  • What are the major brands in Kazakhstan?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Kazakhstan - Industry Overview

EXECUTIVE SUMMARY

Consumer health records double-digit growth

Unit price increase stimulates value growth in 2011

Competitive landscape in hands of multinationals

Chemists/pharmacies continues to dominate consumer health distribution

Good growth opportunities in constant value terms

KEY TRENDS AND DEVELOPMENTS

Strong government regulation

Retailing of medicines in Kazakhstan

Preventive medication stimulates sales growth

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Bioequivalents/Generics

Advertising/promotion

Packaging and Labelling

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2009-2011

SOURCES

  • Summary 2 Research Sources

Consumer Health in Kazakhstan - Company Profiles

Dospharm TOO in Consumer Health (Kazakhstan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Dospharm TOO: Competitive Position 2011

Himpharm AO in Consumer Health (Kazakhstan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Himpharm AO: Competitive Position 2011

Romat Ltd in Consumer Health (Kazakhstan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Romat TOO: Competitive Position 2011

Adult Mouth Care in Kazakhstan - Category Analysis

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

  • Dentinox KG was the leading player in adult mouth care in 2011 with 19% value share derived from its Dentinox brand. However, the brand lost two percentage points in value share in 2011 over the previous year as the strong marketing support seen earlier in the review period faded and consumers became increasingly focused on other available brands.

PROSPECTS

  • Consumer awareness of the importance of oral hygiene will continue to increase over the coming years, especially in urban areas. At the same time, widespread consumption of alcohol and tobacco products, increasing consumption of fast food, confectionery and sweet snacks will also contribute to rising dental problems such as gum disease and tooth decay – a development that will also help to boost demand for adult mouth care products in Kazakhstan.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares 2007-2011
  • Table 14 Adult Mouth Care Brand Shares 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Under-the-counter sales of prescription analgesics continued to be strong at the end of the review period. UTC sales still constitute a significant threat to non-prescription analgesics.

SWITCHES

COMPETITIVE LANDSCAPE

  • Himpharm AO led analgesics in 2011, with a 9% current value share. In September 2011, one of the largest pharmaceutical companies Polharma SA became the major shareholder of the Himpharm AO, thus the global brand owner. The company’s leadership was mainly due to a great deal of customer loyalty, dating back to Soviet times. During the 1990s after the collapse of the Soviet system, its brands Pentalgin P, Paracetamol, and Tetralgin continued to be popular. Affordable prices coupled with several years’ presence in analgesics helped make these brands the most appealing to the population.

PROSPECTS

  • Analgesics is expected to record a forecast period constant retail value CAGR of 3%, which will be an improvement on the review period CAGR of -1%. The high dependence on imports as well as the fact that consumers are trading up to higher quality and less harmful analgesics will underpin value growth over the coming years.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Analgesics Company Shares 2007-2011
  • Table 20 Analgesics Brand Shares 2008-2011
  • Table 21 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Rising stress-related sleeping problems as a result of increasing intensive lifestyles increased demand for calming and sleeping. Furthermore, the rising stress of urban living and working life also contributed to the growth of this category towards the end of the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Lek Pharmaceuticals dd remained as leader of calming and sleeping products in 2011 with a 25% value share, although its share dropped by one percentage point over the previous year. The company’s Persen and Persen Forte brands have a strong base of loyal customers. Although Persen’s share decreased, both brands witnessed their actual value sales increased by 5% and 11%, respectively.

PROSPECTS

  • As stress has become an inevitable consequence of intensive urban lifestyles, and has been identified as a major source of many health problems, the demand for calming and sleeping products is likely to grow further over the forecast period.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2006-2011
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 25 Calming and Sleeping Company Shares 2007-2011
  • Table 26 Calming and Sleeping Brand Shares 2008-2011
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • The demand for cough, cold and allergy (hay fever) remedies is seasonal in Kazakhstan, with sales of cough and cold products increasing in autumn and winter. The performance of the category usually depends on the severity of the winter and autumn seasons. Combination products and cough remedies continued to lead sales during 2011. Due to the increasingly hectic pace of modern life in Kazakhstan, demand for OTC cough and cold remedies is increasing. Local consumers prefer OTC products to prescribed drugs as they do not like to waste time waiting to see a doctor and instead seek qualified advice from pharmacists.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Plc was the steady leader of cough, cold and allergy (hay fever) remedies in 2011with accounted for 7% current value share. The company’s developed distribution network and strong reputation of its brands (mostly Coldrex), recognised for their quality, enabled it to remain a leading player.

PROSPECTS

  • Cough and cold remedies will always be in high demand in Kazakhstan due to the country’s hard climatic conditions and cold and wet winter seasons. Combination products and cough remedies will remain the largest segments over the forecast period, with products in these areas being widely used to reduce symptoms and enable consumers to continue working while suffering from cold or flu symptoms.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Despite rising awareness of the importance of leading a healthier lifestyle in large cities, outside these areas consumers are less concerned with nutrition and often suffer the negative consequences of poor hygiene and high fat diets. In addition, in large cities the popularity of slimming diets is the cause of various digestive disorders. In addition, smoking, alcohol consumption, and rising stress levels for urban residents all contribute to increasing demand for digestive products. Demand for indigestion and heartburn remedies in the country remained strong in 2011, with current retail value sales increasing by 11%. Indigestion and heartburn remedies remained the largest segments within digestive remedies, accounting for 48% share of total current value sales in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 Berlin-Chemie AG was the leading player in digestive remedies, accounting for over14% value share. The company benefited from a strong portfolio of brands, including Mezym Forte and Espumizan, which are well-recognised by Kazakh consumers.

PROSPECTS

  • Over the forecast period, the high incidence of digestive ailments in Kazakhstan due to the traditionally high-fat diet in the country will fuel growth. In addition, levels of alcohol and tobacco consumption and the increasingly stressful pace of modern life will also fuel growth within digestive remedies.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 37 Digestive Remedies Company Shares 2007-2011
  • Table 38 Digestive Remedies Brand Shares 2008-2011
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Consumers suffering from ear ailments typically prefer to seek advice from a doctor instead of self-medicating, with doctors often recommending more expensive but more effective remedies with fewer side effects. The fact that consumers typically use prescription medication to treat ear care problems hampers the potential for OTC ear care growth, with the category remaining relatively small.

SWITCHES

COMPETITIVE LANDSCAPE

  • Biocodex SA, Laboratoires remained the leading player in ear care in 2011, with its Otipax brand alone accounting for 60% value share. This brand has a long history in Kazakhstan and consequently benefits from wide distribution and strong awareness among ear care users. However, Otipax saw the sharpest decline in value share in 2011 over the previous year, dropping by six percentage points. This was chiefly due to stronger competition from other players, as chemists/pharmacies expanded the range of ear care on offer.

PROSPECTS

  • Ear care is expected to see only marginally higher growth during the forecast period, but with positive sales performance with a constant value CAGR of 1%, which is an improvement on the review period CAGR of -1%.Growth will be mainly fuelled by the continued shift towards higher quality and more expensive brands from multinational players and leading local companies.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2006-2011
  • Table 42 Sales of Ear Care: % Value Growth 2006-2011
  • Table 43 Ear Care Company Shares 2007-2011
  • Table 44 Ear Care Brand Shares 2008-2011
  • Table 45 Forecast Sales of Ear Care: Value 2011-2016
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Longer working hours in front of computers resulted in high demand for eye care products towards the end of the review period. The rising incidence of strained eyes and fatigue due to greater use of computers was evident during the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medoptik Co TOO ranked first with a value share of 17% of eye care sales. Dr Mann Pharma GmbH followed with 9% value share. Medoptik is present with the strong brand Dinaf and Neozin, widely recommended by ophthalmologists, while Korneregel by Dr Mann Pharma GmbH was also a best seller. The latter benefited from strong brand recognition, in-store promotion and growth in its base of loyal customers.

PROSPECTS

  • Over the forecast period, growth of the category is due to a sharp rise in household penetration of personal computers, notebooks and the internet. The forecast period is expected to be marked also by the ongoing growth in the use of contact lenses, with this underpinned by rising disposable income levels as the country’s economy grows.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2006-2011
  • Table 48 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 49 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 50 Standard Eye Care by Positioning 2007-2011
  • Table 51 Eye Care Company Shares 2007-2011
  • Table 52 Eye Care Brand Shares 2008-2011
  • Table 53 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of review period, there was growing awareness of an interest in herbal/traditional products. This was partly due to the widening distribution of products such as herbal/traditional calming and sleeping products, digestive remedies, and paediatric dietary supplements. Many herbal/traditional OTC products thus saw a strong performance, with herbal/traditional calming and sleeping products notably witnesses 12% current value growth in 2011 over the previous year’s 3% increase. Herbal/traditional digestive remedies and herbal/traditional paediatric dietary supplements both witnessed 17% growth.

COMPETITIVE LANDSCAPE

  • Unique Pharmaceutical Laboratories led herbal/traditional products in 2011 with 12% value share. Its Doktor Mom brand, offering medicines to treat sore throats and coughs has gained popularity and consumers’ loyalty through years of operation. The availability of its remedies in three formats (cough drops, ointment and syrup) at lower prices compared to standard products drove sales of the brand.

PROSPECTS

  • Over the forecast period, increasing awareness of the importance of leading a healthy lifestyle will continue to raise demand for herbal/traditional products in Kazakhstan. These products are considered to be healthier alternatives to chemical-based medicines, with fewer or no side effects, and are very important to key consumer groups – children, elderly people and rural consumers. This in turn, explains the significantly higher growth rate for herbal/traditional products over the forecast period, with a CAGR of 7% in constant value terms than what was achieved over the review period. However, chemical-based OTC and Rx products will be a potential threat to forecast period growth.

CATEGORY DATA

  • Table 55 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 56 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 57 Herbal/Traditional Products Company Shares 2007-2011
  • Table 58 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 59 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 60 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • 2011 was marked by the widening product range and rising consumer product awareness. Furthermore, increased incidences of self-medication also supported growth. The fact that many consumers view skin ailments as being rather embarrassing means that they often prefer to purchase well-promoted OTC products based on their own experience, advertising and advice from pharmacists. Rising urban population and stress levels in Kazakhstan are also resulting in an increase in the incidence of skin problems. Consequently, the majority of consumers of medicated skin care products in the country are urban citizens of all ages.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer AG was the leading player in medicated skin care in 2011 for a second consecutive year with 9% current value share, despite the fact that the company recorded the largest decrease in current value sales towards the end of review period by half a percentage point. This was largely due to the increasing popularity of other brands which enjoyed wider distribution coverage. Bayer AG, in its turn, benefited from the popularity of its Neo Penotran Forte and Neo Penotran under vaginal antifungals.

PROSPECTS

  • Over the forecast period, poor nutrition, pollution, poor hygiene and the increasing incidence of sexually transmitted diseases, along with the growing number of allergy and acne sufferers, will boost demand for medicated skin care products in Kazakhstan over the coming years.

CATEGORY DATA

  • Table 61 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 62 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 63 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 64 Medicated Skin Care Brand Shares 2008-2011
  • Table 65 Hair Loss Treatments Brand Shares 2008-2011
  • Table 66 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 67 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Kazakhstan’s authorities have become increasingly concerned with the problem of smoking. The public smoking ban, which came into force in late 2009 and the rise in excise tax in 2010, led to falling numbers of smokers in Kazakhstan. The government is actively seeking to reduce the number of smokers in the country. Tightening of regulations made smoking less attractive, causing smokers to think about quitting the habit. As a result, smoking cessation aids became more popular in the country. A number of very strong anti-smoking commercials were broadcast on television during the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • By the end of 2011, GlaxoSmithKline had maintained its position as category leader with 59% value share, because of its first-mover advantage as well as brand recognition among users.

PROSPECTS

  • The government of Kazakhstan will continue its efforts on tightening regulations related to tobacco smoking, such as enacting a stricter law for the ban on smoking in public places. This will be the main driver of smoking cessation aids over the forecast period.

CATEGORY INDICATORS

  • Table 68 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 69 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 70 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 71 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 72 NRT Smoking Cessation Aids Company Shares 2007-2011
  • Table 73 NRT Smoking Cessation Aids Brand Shares 2008-2011
  • Table 74 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 75 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Demand for sports nutrition remained limited to sportsmen and professional sports trainers in 2011, with the majority of consumers in Kazakhstan remaining unaware of the availability of such products. On the other hand, the rising trend for healthy living led people to take up sporting activities. Consequently, the number of gymnasiums and sports centres continued to rise.

COMPETITIVE LANDSCAPE

  • Weider Nutrition International Inc and Atlantic Multipower Germany GmbH & Co oHG led sales with 20% current value share each. Their brands have been available in Kazakhstan for many years and gained loyal customers and the respect of professionals. Their high quality and standard price made them top-selling brands.

PROSPECTS

  • Over the forecast period, sports nutrition sales are expected to expand as more people are attracted by the fitness trend. Companies will try to suit consumer needs by developing more relevant products for different groups, switching to classification based on functions, benefit and gender.

CATEGORY DATA

  • Table 76 Sales of Sports Nutrition: Value 2006-2011
  • Table 77 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 78 Sports Nutrition Company Shares 2007-2011
  • Table 79 Sports Nutrition Brand Shares 2008-2011
  • Table 80 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 81 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Growth within vitamins and dietary supplements was supported by the desire to lead a healthy lifestyle. However, this trend was mainly limited to urban areas, with consumers in rural areas still having relatively low awareness of the benefits of vitamins and dietary supplements. On the other hand, the absence of reliable vaccines and novelty of the influenza diseases made people focus on switching to preventative means. Advice from professionals in the field of public health on immunity and general health issues supported a mainstream trend towards preventative medication.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Unipharm Inc led sales with 15% value share in 2011 due to its brand Vitrum’s popularity. This leading position is also due to the company’s wide ranging portfolio, reputation for quality and strong sales techniques.

PROSPECTS

  • Rising consumer health awareness will fuel sales of vitamins and dietary supplements in Kazakhstan over the forecast period. Increasing disposable incomes will allow consumers to spend more money on their health. In addition, advertising will also remain very important for boosting value sales.

CATEGORY DATA

  • Summary 12 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 82 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 83 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 84 Dietary Supplements by Positioning 2007-2011
  • Table 85 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 86 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 87 Vitamins Brand Shares 2008-2011
  • Table 88 Dietary Supplements Brand Shares 2008-2011
  • Table 89 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 90 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Weight management continued to increase in popularity in Kazakhstan due to the growing number of overweight people in the country. Slimming products are a good alternative to those which tackle obesity, which are only available in limited numbers and are perceived as being expensive by consumers. Although local people are concerned about their health and appearance, per capita sales of weight management slimming remained negligible in the country, with the majority of the population still preferring to reduce food consumption or to go to sports clubs instead of purchasing slimming products on a regular basis.

COMPETITIVE LANDSCAPE

  • Laboratory Vitarmonil led sales in 2011, recording a retail value share of 31%, although it recorded the largest decline in retail value share (by one and a half percentage points).Its continued leadership was due to the popularity of the company’s AcvaLine brand. However, towards the end of the review period, the brand experienced a weakness in distribution coverage. As a result, the share of others increased, rising by one percentage point, which was the largest increase in current value sales during 2011.

PROSPECTS

  • Over the forecast period, the number of overweight people in Kazakhstan will continue to grow towards the end of the forecast period. Most women looking to lose weight will continue to rely on dieting and leading a healthy lifestyle as opposed to slimming tablets over the coming years. However, there has also been negative press coverage of many different diets. The image of weight loss supplements will improve and the customer base will widen.

CATEGORY DATA

  • Table 91 Sales of Weight Management by Category: Value 2006-2011
  • Table 92 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 93 Weight Management Company Shares 2007-2011
  • Table 94 Weight Management Brand Shares 2008-2011
  • Table 95 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 96 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Kazakhstan - Category Analysis

HEADLINES

TRENDS

  • Growth of wound care was largely boosted by rising demand for more convenient products. The share of expensive products continued to steadily increase within wound treatments, especially within sticking plasters. In 2011, sticking plasters/adhesive bandages accounted for 65% share of wound care current retail value sales in Kazakhstan; two percentage points increase from 2010.

COMPETITIVE LANDSCAPE

  • Gigrovata-Saint-Petersburg ZAO sustained its leadership of wound care, holding 30% value share in 2011. Its closest competitors are Veropharm ZAO, with over 16% value share, and Johnson & Johnson Inc, with a 11% value share. These companies’ products are widely available throughout the country.

PROSPECTS

  • Wound care is predicted to experience marginal decline over the forecast period. The growth rate will be fuelled by the demand for lower-priced products. However, growing consumer awareness of new products available and switches of consumption towards more convenient but expensive solutions are not excluded. Due to that, compared to the review period constant value CAGR of -3%, the forecast period decline will not be as drastic..

CATEGORY DATA

  • Table 97 Sales of Wound Care by Category: Value 2006-2011
  • Table 98 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 99 Wound Care Company Shares 2007-2011
  • Table 100 Wound Care Brand Shares 2008-2011
  • Table 101 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 102 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!